Recruitment intervention and effect on participation
Recruitment interventionReference ID | Increases | Decreases | Little impact | Inconclusive |
---|---|---|---|---|
Trial design | ||||
Open design16 32 | ● | |||
Placebo* 59 | ⊙ | |||
Patient preference design18 | ⊙ | |||
Zelen design†25 | ⊙ | |||
Internet-based data capture†42 | ⊙ | |||
Obtaining consent | ||||
Process—opt-out approach55 | ⊙ | |||
Process—consent to experimental treatment*48 50 | ● | |||
Process—consent to standard treatment*48 50 | ● | |||
Process—refuser chooses treatment option*50 | ⊙ | |||
Process—physician modified chance of experimental*48 | ⊙ | |||
Process—participant modified chance of experimental*48 | ⊙ | |||
Form—researcher read aloud56 | ⊙ | |||
Form—altered readability level†19 | ⊙ | |||
Approach to participants | ||||
Delivery—video presentation*†28 35 | ● | |||
Delivery—video presentation plus written information60 | ⊙ | |||
Delivery—audiovisual overview of trials21 22 33 | ● | |||
Delivery—interactive computer presentation*36 44 | ● | |||
Delivery—verbal education session45 | ⊙ | |||
Supplementing info—booklet on clinical trials*23 34 | ● | |||
Supplementing info—study-relevant questionnaire31 37 | ● | |||
Supplementing info—newspaper article51 | ⊙ | |||
Framing—treatment as faster*52 | ⊙ | |||
Framing—treatment as new*38 | ⊙ | |||
Framing—emphasis on pain or risk*54 | ⊙ | |||
Framing—positively or negatively*43 | ⊙ | |||
Content—more detailed info (inc. total disclosure)*27 53 | ● | |||
Content—financial disclosure of investigator interest*†57 58 | ● | |||
Telephone reminders31 49 | ● | |||
SMS messages26 | ⊙ | |||
Eligibility screening—face-to-face*24 29 | ● | |||
Eligibility screening—telephone*20 | ⊙ | |||
Eligibility screening—electronic self-complete*29 | ⊙ | |||
Screening personnel46 | ⊙ | |||
Financial incentives | ||||
Cash incentive with invitation26 | ⊙ | |||
Paid participation*†17 30 | ● | |||
Level of trial risk*†17 30 | ● | |||
Training for recruiters | ||||
Training lay advocates†40 | ⊙ | |||
Education sessions†39 | ⊙ | |||
Trial co-ordination | ||||
On-site visits†41 | ⊙ | |||
Additional communication†47 | ⊙ |
●, Multiple studies; ⊙, single study.
*Includes recruitment to hypothetical trial(s).
†Includes result reported by study authors only (effect size not calculated).